Epix CEO resigns

Epix Pharmaceuticals CEO Dr. Michael Kauffman, Ph.D., has resigned his post to pursue other business opportunities.

The Lexington, MA-based contrast agent developer has named Elkan Gamzu, Ph.D., as interim CEO, effective immediately. Gamzu is currently a consultant to the biotechnology and pharmaceutical industries, Epix said.

Related Reading

Epix wins South Korean approval of Vasovist, July 10, 2008

Epix resubmits Vasovist NDA, July 1, 2008

Epix president resigns, May 29, 2008

Epix to resubmit NDA for Vasovist, April 24, 2008

Epix reaches agreement with FDA over Vasovist, February 1, 2008

Copyright © 2008 AuntMinnie.com

Page 1 of 610
Next Page